These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 8562257

  • 1. [The role of the sympathetic nervous system in essential arterial hypertension and organ damage].
    Grassi G, Mancia G.
    Ann Ital Med Int; 1995 Oct; 10 Suppl():115S-120S. PubMed ID: 8562257
    [Abstract] [Full Text] [Related]

  • 2. Early and late sympathetic activation in hypertension.
    Mancia G, Di Rienzo M, Giannattasio C, Parati G, Grassi G.
    Scand Cardiovasc J Suppl; 1998 Oct; 47():9-14. PubMed ID: 9540128
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G, Di Rienzo M, Parati G, Grassi G.
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [Abstract] [Full Text] [Related]

  • 5. [Autonomic nervous system in arterial hypertension].
    Grassi G.
    Ital Heart J Suppl; 2001 Aug; 2(8):850-6. PubMed ID: 11582717
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High blood pressure management: potential benefits of I1 agents.
    Esler M.
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.
    Grassi G.
    Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J, Karas M, Toal C, Nadeau R, Larochelle P.
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases.
    Esler M.
    J Cardiovasc Pharmacol; 1995 Mar; 26 Suppl 2():S24-8. PubMed ID: 8642801
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
    Julius S.
    Eur Heart J; 1998 Jun; 19 Suppl F():F14-8. PubMed ID: 9651730
    [Abstract] [Full Text] [Related]

  • 20. Baroreflexes and cardiovascular regulation in hypertension.
    Head GA.
    J Cardiovasc Pharmacol; 1995 Jun; 26 Suppl 2():S7-16. PubMed ID: 8642810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.